Showing 1 - 3 results of 3 for search 'Jonathan Hazlehurst', query time: 0.03s Refine Results
  1. 1
    Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study

    Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study by Zhaonan Wang, Jonathan Hazlehurst, Jonathan Hazlehurst, Jonathan Hazlehurst, Anuradhaa Subramanian, Abd A. Tahrani, Abd A. Tahrani, Abd A. Tahrani, Wasim Hanif, Neil Thomas, Pushpa Singh, Pushpa Singh, Jingya Wang, Christopher Sainsbury, Christopher Sainsbury, Krishnarajah Nirantharakumar, Krishnarajah Nirantharakumar, Krishnarajah Nirantharakumar, Francesca L. Crowe

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Sodium‐glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin‐resistant patients without type 2 diabetes

    Sodium‐glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin‐resistant patients without type 2 diabetes by Thomas Marjot, Charlotte J Green, Catriona A Charlton, Thomas Cornfield, Jonathan Hazlehurst, Ahmad Moolla, Sarah White, Jane Francis, Stefan Neubauer, Jeremy FL Cobbold, Leanne Hodson, Jeremy W Tomlinson

    Published 2020-06-01
    Get full text
    Article
  3. 3
    Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia

    Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia by Jonathan Hazlehurst, Bernard Khoo, Carolina Brito Lobato, Ibiyemi Ilesanmi, Sally Abbott, Tin Chan, Sanesh Pillai, Kate Maslin, Sanjay Purkayastha, Barbara McGowan, Rob Andrews, Eveleigh Nicholson, Katherine McCullough, Lorraine Albon, Rachel Batterham, Georgios K Dimitriaidis, Shareen Forbes, Gavin Bewick, Tricia M-M Tan

    Published 2024-04-01
    Get full text
    Article

Search Tools: